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TransportomeAn elaborate interplay between ion channels and transporters, components of the cytoskeleton, adhesion
molecules, and signaling cascades provides the basis for each major step of the metastatic cascade. Ion channels
and transporters contribute to cell motility by letting through or transporting ions essential for local Ca2+, pH
and – in cooperation with water permeable aquaporins – volume homeostasis. Moreover, in addition to the
actual ion transport they, or their auxiliary subunits, can display non-conducting activities. They can exert kinase
activity in order to phosphorylate cytoskeletal constituents or their associates. They can become part of signaling
processes by permeating Ca2+, by generating local pH-nanodomains or by being ﬁnal downstream effectors. A
number of channels and transporters are found at focal adhesions, interacting directly or indirectlywith proteins
of the extracellular matrix, with integrins or with components of the cytoskeleton. We also include the role of
aquaporins in cell motility. They drive the outgrowth of lamellipodia/invadopodia or control the number of β1
integrins in the plasma membrane.
Themultitude of interacting ion channels and transporters (called transportome) including the associated signal-
ing events holds great potential as therapeutic target(s) for anticancer agents that are aimed at preventing
metastasis. This article is part of a Special Issue entitled: Membrane channels and transporters in cancers.
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Metastasis is based on a complex, multi-step process called the
metastatic cascade [1]. In carcinomas, i.e. tumors developing from epi-
thelial cells, the metastatic cascade typically begins with an epithelial–
mesenchymal transition (EMT), another multi-step process, duringne channels and transporters in
+49 511 532 8173.
tock).which cells, originally featuring epithelial characteristics transmute
into cells that display mesenchymal characteristics [2]. To acquire a
mesenchymal phenotype, epithelial cells that are usually attached to a
basement membrane undergo numerous biochemical and molecular
changes such as the activation of transcription factors, the modiﬁed ex-
pression of speciﬁc cell-surface proteins, the expression and reorganiza-
tion of cytoskeletal proteins, changes in microRNA expression and
secretion of ECM (extracellular matrix) — degrading enzymes. These
changes are accompanied by a loss of cell–cell contacts, an increase in
cell motility (migration and invasiveness), a strengthened resistance
to apoptosis, and an enhanced production of matrix components [2].
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EMT occurs in an orderly way and is terminated by its reverse process
called MET (mesenchymal–epithelial transition), whereas the acquisi-
tion of an invasive, eventually metastatic phenotype due to a delay or
even a lack of a controlled MET represents EMT's pathological
potential. EMT is accompanied by changes in the expression patterns
of transcription factors such as SNAIL, TWIST or ZEBs which leads to a
downregulated expression of E-cadherin, ZO1, claudins and occludins
and an upregulated expression of N-cadherin, ECM components such
as collagens and ﬁbronectin, and matrix metalloproteases (MMPs) [3].
It is conceivable that ion channels and transporters are involved in
EMT since their expression is aswellmodulated by transcription factors.
For instance, the unscheduled expression of a neonatal splice variant of
the voltage gated sodium channel Nav1.5 (nNav1.5) clearly correlates
with migration and invasion of metastatic breast cancer [4–6].
In general, a malfunctioning or oncogenic EMT can lead to metasta-
ble cellular phenotypes combining both epithelial and mesenchymal
characteristics [7]. EMT includes loss of contact inhibition and the
cells' ability to break out of the organized tissue structure [8–10]. The
following detachment from the primary tumor requires the release of
intercellular junctions that are typically mediated by cadherins or
integrins [11,12]. The next step in the metastatic cascade is the cellular
invasion of the surrounding stroma. For this purpose cells remodel the
extracellular matrix by secreting matrix metalloproteinases and simul-
taneously exhibit a dynamic cell–substrate interaction in order to
migrate directionally [13]. The migrating cells eventually enter the vas-
culature or the lymphatic systemwhere they become circulating tumor
cells as they are being carried away by the blood or lymph stream. Only
a very small percentage of these circulating tumor cells survive the ex-
tracellular milieu and adhere to the endothelium at a distant site [14].
The cells then extravasate and invade the surrounding tissue in order
to form a metastasis which ﬁnally develops a full-grown secondary
tumor [15]. All four steps of the metastatic cascade, (i) loss of cell–cell
contacts, (ii) invasion of the surrounding stroma and the vasculature,
(iii) adhesion to the endothelium, and (iv) extravasation into the tissue
of the target organ require the presence and/or concerted action of ion
channels and/or transporters (Fig. 1, Table 1), also referred to as
migration-associated transportome [16].
2. EMT and loss of cell–cell contacts
Oncogenic epithelial–mesenchymal transition (EMT) is based on a
coordinated gene expression program, includes the early steps ofmalig-
nant transformation and is accompanied by a gain of pro-metastatic
properties such as an increased basal motility including invasion and
cancer stem cell characteristics [17–19]. A loss of cell–cell contacts can
be induced by ectopic expression of carbonic anhydrase IX (CAIX)
which results in the redistribution of CAIX and its pH-regulatory inter-
action partners, the Na+,HCO3− cotransporter NBC and the anion ex-
changer AE2, to the leading edge where they can fulﬁl tasks required
for cell migration and invasion [20]. Thus, several ion transport proteins
are involved in this process of epithelial–mesenchymal transition
(EMT). Whether or not and to what extent other transport proteins as-
sociated with tumor metabolism, such as the Na+/H+ exchanger NHE1
or, monocarboxylate transporters (MCTs), or aquaporins contribute to
EMT remains to be elucidated.
A Cl− and HCO3− conducting channel, known as the cystic ﬁbrosis
transmembrane conductance regulator (CFTR), plays a role as an EMT
suppressor in the human breast adenocarcinoma cell lines MCF-7 and
MDA-MB-231 [21]. Both the presence and the function of CFTR decrease
the metastatic potential of MCF-7 cells. Conversely, CFTR knockdown
reduces the strength of cell–cell contacts by decreasing the expression
of E-cadherin and occludins and – like the functional inhibition with
inh172 or GlyH101 – leads to a dramatic increase inmigration and inva-
sion. On the same lines, the physical interaction of CFTR with the scaf-
folding protein NHERF1 (Na+/H+ exchanger regulatory factor1) in aCFTR–NHERF1–ezrin–actin multiprotein complex stabilizes cell–cell
junctions through the tight-junction protein ZO-1 [22]. In nude mice,
the growth of implanted MDA-MB-231 cells that overexpress CFTR is
not reduced while the metastatic potential is clearly decreased, and in
clinical breast cancer samples a low CFTR expression correlates with
disease progression and poor prognosis [21]. Consistently, CFTR overex-
pression suppresses EMT and invasive behavior inMDA-MB-231 cells. A
functional CFTR has been shown to control NFκB-mediated inﬂammato-
ry signaling [23,24]. Knocking down CFTR leads to activation of NFκB,
while conversely, the inhibition of NFκB countermands CFTR
knockdown-induced EMT and the development of an invasive pheno-
type in MCF-7 cells. This indicates that CFTR acts as a tumor suppressor
by tightly controlling NFκB-signaling via its ion-conducting function
[21]. Studies employing a structurally functioning but at the same
time transport-deﬁcient CFTR could help clarify as towhat extent purely
structural protein interactions determine cell–cell adhesion and impact
on malignancy. Interestingly, in colon cancer cells, CFTR and the
adherens junction molecule AF-6/afadin physically interact at cell–cell
contacts. When CFTR is knocked down these cells display an enhanced
invasive phenotype which can be completely reversed by either AF-6/
afadin overexpression or inhibition of ERK, indicating the involvement
of the AF-6/MAPK pathway [25].
Calcium signaling mediated by calcium-permeable ion channels in-
cluding the transient receptor potential-melastatin-like 7 (TRPM7)
channel contributes to EMT in breast cancer, too [26]. Chelation of intra-
cellular Ca2+ by BAPTA or EGTA reduces EGF- and hypoxia-induced
EMT and inhibits the EGF-dependent activation of signal transducer
and activator of transcription 3 (STAT3), probably including CaMK/
NFκB signaling [27], while leaving the Akt and ERK1/2 pathways entire-
ly unaffected. Since silencing TRPM7 inhibits only parts of the EGF-
induced processes inhibited by Ca2+ chelation, additional Ca2+
channels or -transporters other than TRPM7 must be involved [26].
The Ca2+-activated KCa3.1 channel (KCNN4, IK1) participates in the
EMT of colorectal cancer [28]. Stimulation of KCa3.1 expression by phos-
phatase of regenerating liver-3 (PRL-3) is accompanied by an elevation
of the cytosolic Ca2+-concentration [Ca2+]i through an unknown
mechanism, possibly through a constitutive entry through voltage-
independent Ca2+-permeable channels under hyperpolarization of the
membrane potential. This increase in [Ca2+]i causes a constitutive auto-
phosphorylation of CaM-kinase II leading to phosphorylation of GSK-3β
[29]. In human colon adenocarcinoma cells (LoVo) transfected with
PRL-3, the expression levels of phosphorylated GSK-3β and the tran-
scription factor SNAIL are increased. The increased expression of these
proteins can be repressed by both KCa3.1 siRNA and the speciﬁc channel
blocker TRAM-34 [28]. SNAIL inhibits E-cadherin expression not only in
colorectal cancer [28] but also in breast cancer cells [30] promoting the
loss of cell–cell contacts characteristic of EMT [3].
EMT is accompanied by a loss of cell contact inhibition. NIH3T3-cells
stably transfectedwith Kv11.1 (hERG1) channels show a loss of cell con-
tact inhibition. In culture, these cells grow inmultiple layers and at high
density [31]. Interestingly, their morphology changes from ﬁbroblast-
like to spindle-shaped while both the degree of cell polarization and
migration increase. Furthermore, allogeneic transplantation of hERG1-
expressing cells into nude mice leads to an increased incidence of
tumors [31].
3. Invading the surrounding stroma and vasculature
In addition to being involved in EMT TRPM7 contributes to a more
migratory and invasive phenotype [32], so that in human breast cancers,
the expression level of TRPM7 and the formation of metastases are pos-
itively correlated. Knocking down TRPM7 leads to elevatedmyosin light
chain (MLC) — and paxillin phosphorylation including an increased
number of focal adhesions [33]. The resulting increases in contractility
and adhesion strength cause a signiﬁcant decrease in cell motility and
thus metastasis. In this process TRPM7 functions via a “dual mode of
Tissue 1
Tissue 2/
ECM
Target
tissue
BM
BM
BM
endothelium
(1) EMT & Loss of cell-cell contacts:
CAIX          NBC, AE2
CFTR   , TRPM7, KCa3.1, Kv11.1    
? nNav1.5 ? NHE1? MCTs ? AQPs ?
(2) Invasion of stroma & vasculature:
TRPC1,TRPM7, P2X7, VGSC ( -subunits; 
Nav1.5), STIM1, Orai1, KCa3.1, KCa2.3, ClC-3, 
TMEM16A/ANO1, NHE1, NBCn1, AE2, NKCC, 
AQPs, CAs, MTCs   
(3) Adhesion to endothelium:
- Mechanosensitive / stretch activated, e.g. 
? KCa1.1 ? KCNK2 ? Nav1.5 ? NHE1 ? TRPs ? NCXs?
- Kv11.1- 1Integrin interaction  
- CLC2A2- 4 Integrin interaction 
(4) Extravasation:
- Orai1, TMEM16A/ANO1
Fig. 1. Different steps of the metastatic cascade and the ion channels and transporters involved. (1) EMT can be induced by ectopic expression of CAIX leading to a redistribution of NBCs
and the anion exchanger AE2which enablesmigration. Downregulation of CFTR leads to a loss of cell–cell contacts. Ca2+ signalingmediated by TRPM7 accompanies theprocess of EMT. An
increase in KCa3.1 expression causes a loss of cell–cell contacts and transfection with Kv11.1 induces a loss of contact inhibition. The involvement of Nav1.5, NHE1, MCTs and AQPs is pos-
sible and conceivable but so far has not been shown explicitly. (2) Numerous ion channels and transporters have been shown to contribute to cell motility and invasion. The transported
ions (Na+ through NHE1, NKCC, VGSC; K+ through KCa3.1, KCa2.3, NKCC; Cl− through AE2, ClC-3, TMEM16A/ANO1, NKCC) trigger the movement of water through AQPs so that local os-
motic swelling and shrinkage facilitate cell movement across a densemeshwork of ECM ﬁbers. Ca2+ entry (through TRPC1, TRPM7, P2X7, STIM1, Orai1) stimulates the activities of kinases
and Ca2+ activated channels (e.g. KCa3.1, KCa2.3), and Ca2+ signaling impacts on cytoskeletal dynamics. pH nanodomains controlled by NHE1, NBCn1, AEs and CAs modulate cytoskeletal
dynamics, adhesion and intra- and extracellular enzyme activities including MMP and cathepsin. In addition to promoting NHE1 activity and cathepsin release, β-subunits of Nav1.5 can
serve as adhesionmolecules. (3) In leukemia, adhesion to the endothelium could be facilitated by the interaction between Kv11.1 and β1 integrin. In circulating tumor cells, CLCA2 located
at the endothelial surface can catch tumor cells by binding to the tumor cell'sβ4 integrin.Whether or not the shear stress in the vessel causesmechanosensitive channels and transporters
such as KCa1.1, KCNK2, Nav1.5, NHE1, members of the TRP and NCX families or others to contribute to adhesion and subsequent diapedesis can only be speculated. (4) Extravasation of
nasopharyngeal cells requires the Ca2+ release-activated calcium channel protein 1 (Orai1). The step of diapedesis could also be facilitated by the Ca2+-dependent activation of
TMEM16A/ANO1. The resulting Cl− efﬂux would support local shrinkage of the evading cell and thus help the cell to squeeze its way into the target tissue. Please see text and Table 1
for further details and references. BM= basement membrane, ECM= extracellular matrix.
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creases of [Ca2+]i, called Ca2+ ﬂickers [35], while its kinase activity in-
duces the phosphorylation of myosin IIA heavy chain and eventually
the transformation of focal adhesion sites into podosomes [36].
Similarly, independently of the actual ion translocation, the β sub-
units of voltage-gated sodium channels (VGSCs) exhibit a variety of
functions contributing to the malignancy of breast cancer cells. They
mediate tumor growth and promote invasion by facilitating the out-
growth of protrusions [37]. The β subunits are involved also in channel
gating, and even in the absence of the pore-forming α subunits, they
function as cell adhesion molecules [38]. The β1 subunits contribute to
cellular aggregation and ankyrin-recruitment to cell–cell contacts by
trans-homophilic adhesion [39,40]. In addition, they can interact
heterophilically with the extracellular matrix protein tenascin-R [41],
with β2 subunits [42], with N-Cadherin [43], NrCAM [42], contactin
[44] and neurofascins [45].3.1. The role of Ca2+
In general, [Ca2+]i has a major effect on the cellular migration
machinery. Many constituents of the cytoskeletal migration machinery
such as the above-mentioned myosin-light chain kinase (MLCK) [46],
myosin II [47,48], calpain [49], Ca2+ calmodulin-dependent protein
kinase II [50,51] and the focal adhesion kinase [52] are Ca2+ sensitive.
[Ca2+]i generates a myosin II-dependent contractile force leading to
the retraction of the rear part of a migrating cell [53]. Strikingly, tiny,
local Ca2+ pulses occurring at the cell front only a few micrometers
behind the leading edge trigger the withdrawal of deﬁned areas of the
lamellipodium by activating MLCK and myosin II-mediated contraction
[46]. Fittingly, STIM1, a constituent of the store-operated Ca2+ entry
(SOCE) channel, is found close to the leading edge of endothelial cells
[54] and pancreatic ductal adenocarcinoma (PDAC) cells [55]. Another
component responding to [Ca2+]i is the actin-binding protein α-actinin
Table 1
Ion channels and transporters in different steps of the metastatic cascade.
Step Ion channel/transporter and its mode of action Reference
EMT CAIX ⇒ ectopic expression induces loss of cell–cell contacts and redistribution of NBC and AE2 to the leading edge [20]
CFTR ⇒ EMT suppressor
– In breast cancer, controlling NFκB signaling, via its ion-conducting function [21]
– Through structural interaction at tight and adherens junctions [22,25]
TRPM7 ⇒ contributes to Ca2+ signaling leading to EMT [26,27]
KCa3.1 ⇒ increased expression contributes to EMT in colorectal cancer [28]
Kv11.1 ⇒ loss of cell contact inhibition [31]
Invading stroma & vasculature TRPM7 ⇒ increase in cytosolic Ca2+ & kinase activity = N podosome formation [32–36]
TRPM8 ⇒ contributes to invasiveness of oral squamous carcinoma via Ca2+ [141]
TRPV2 ⇒ promotes prostate cancer cell migration [142]
STIM1 (constituent of SOCE) ⇒ polarized distribution in migrating PDAC
– local [Ca2+]i increases affect cytoskeletal dynamics & kinase/channel activity.
[54,55]
TRPC1 ⇒ local [Ca2+]i affects cytoskeletal dynamics & kinase/channel activity [61]
KCa3.1 ⇒ local osmotic effects in glioma cells facilitate invasion [58–60,62]
KCa2.3 + Orai1 ⇒ breast cancer cell migration and bone metastases [63,70]
ClC-3 ⇒ local osmotic effects in glioma cells facilitate invasion [50,58–61]
AQP2 ⇒ supports migration by facilitating integrin turnover [95]
AQP3 ⇒ migration of breast cancer cells [83]
AQP4 ⇒ migration and invasion of glioma cells [86]
AQP5 ⇒ proliferation and migration of gastric cancer cells [88]
AQP8 ⇒ increases invasive potential of cervical cancer cells [89]
NHE1 ⇒ promotes motility and invasion by
– Osmotic effects [75]
– Generation of local pHe/pHi environments at focal adhesions [101,106–108]
– Contributes to migration of melanoma, breast cancer, cervical cancer cells [101–105]
– Stimulates focal matrix digestion by local acidiﬁcation [133–135]
AEs/AE2 ⇒ involved in cell motility by osmotic effects and pH regulation
– Contributes to malignancy in hepatocellular carcinoma, gastric cancer and colonic carcinogenesis
[77,119]
[123–125]
[127,128]
[126]
NBCn1 ⇒ involved in pH homeostasis of malignant breast cancer cells [118,121]
NKCC ⇒ osmotic effects [78]
VGSC (voltage gated sodium channels) ⇒ β subunits
– Support outgrowth of protrusions [37]
– Involved in channel gating, function as adhesion molecules [38]
– β1 subunits mediate cell–cell contacts via trans-homophilic adhesions and heterophilic interaction with matrix and
cell surface-proteins
[39–45]
Nav1.5 ⇒ elevates metastatic potential of breast cancer by increasing
– NHE1 activity [138]
– Cysteine cathepsin activity [139]
[140]
P2X7 ⇒ increases breast cancer invasion by Ca2+ depend. cathepsin release [144]
Adhesion diapedesis Kv11.1 ⇒ interacts physically and functionally with β1 integrin in leukemia [149–152]
– Activated by integrin binding, activates FAK activity [152,153]
CLCA2 ⇒ located in endothelia, interacts with β4 integrins on tumor cells [155]
Orai1 ⇒ required for extravasation of nasopharyngeal cancer cells [156]
TMEM16A/ANO ⇒ could facilitate diapedesis by local shrinkage [68]
Response to shear stress?? Mechanosensitive channels and transporters: KCa1.1, KCNK2, Nav1.5, NHE1, members of TRP
and NCX families, others??
?
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actin bundling activity is inhibited by an increase in [Ca2+]i [57]. An
increase in [Ca2+]i is also needed for the simultaneous activation of
the K+ channel KCa3.1 and the CaMKII-regulated Cl− channel ClC-3
[58]. Both channels contribute to glioma malignancy by promoting mi-
gration and invasion [59,60]. The requiredCa2+ entry is at least partially
mediated by stretch activated TRPC1 channels (transient receptor po-
tential cation channel 1) co-localizing with ClC-3 in lipid rafts of glioma
cell processes since knocking down TRPC1 expressionwith shRNA leads
to a decrease in Cl− currents in a Ca2+ dependentway [61]. In addition,
Ca2+ release from intracellular stores, frequently induced by growth
factor signaling and mediated by IP3, contributes to the required in-
crease in [Ca2+]i. The Ca2+ induced activation of KCa3.1 [62], KCa2.3
[63], ClC-3 [50,61] or the Cl− conducting TMEM16A/ANO1 [64–66],
leads to a simultaneous efﬂux of K+ and Cl− ions and eventually to a
local, osmotic cell shrinkage [59,67,68], facilitating not only the global,
Ca2+-dependent retraction of the rear end of a migrating cell but also
the ﬁne-tuned process of squeezing through constrictions of the ECM
meshwork [69].A constitutive Ca2+ entry promoting cancer cell migration and bone
metastasis can also be accomplished by an intriguingly synergistic inter-
action between the voltage-independent Ca2+ channel Orai1 and the
small conductance Ca2+ activated potassium channel KCa2.3 inside
lipid rafts [70]. Treatment with the alkyl–lipid Ohmline disperses the
lipid rafts and the KCa2.3–Orai1 complex, resulting in an impairment
of the KCa2.3-dependent Ca2+ entry, migration and metastasis.
3.2. Cell volume dynamics
Cells migrating on a substrate perform a repetitive cycle of protru-
sion of the lamellipodium and retraction of the rear part. Instead of
lamellipodia, invasive cells develop functionally similar invadopodia
[71] to explore and invade the ECM. Both the outgrowth of lamellipodia
or invadopodia and the retraction of the rear end require local swelling
and shrinkage, respectively [72–74]. These osmotic events are based on
(i) local ion transport through the Na+/H+ exchanger NHE1 [75], the
Na+,HCO3− cotransporter [76], the Cl−/HCO3− exchanger AE [77], and
the Na+, K+, 2Cl− cotransporter NKCC [78] at the leading edge/tip of
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across the above-mentioned K+ and Cl− channels, and (iii) water mole-
cules concomitantly passing through aquaporins [79] such as AQP1 [80],
AQP3 [81–83], AQP4 [84–86], AQP5 [87,88], AQP8 [89], andAQP9 [90]. In
human breast cancer (MDA-MB-231) and murine sarcoma (S180) cells,
repetitive cycles of local, NHE1-dependent swelling at the cell front and
shrinkage at its rear enable the cells to move independently of actin
polymerization, myosin II, and integrin-mediated adhesion [91]. This
may be the central mechanism underlying the rounded/amoeboid
tumor cell migration mode that allows cell movement through a dense
extracellular matrix without matrix degradation [92–94].
An intriguing function of AQPs has been shown for AQP9 [90]. AQP9
accumulates at certain sites in the plasma membrane. The resulting
rapid, local water inﬂux generates a hydrostatic pressure detaching
the membrane from the cytoskeleton and pushing the membrane
outwards. Previously membrane-anchored barbed end actin is now
exposed and promotes actin polymerization in cooperation with actin
monomers rapidly diffusing into the less viscous cytoplasm. This con-
certed action between local swelling and actin-polymerization controls
the outgrowth of lamellipodia, ﬁlopodia or invadopodia.
Besides the permeation of water molecules a second mechanism by
which AQPs act on cell motility has been shown for kidney epithelial
cells [95]. AQP2 modulates the intracellular trafﬁcking and subsequent
cell surface presentation of the adhesion molecule integrin β1 by
displaying a potential RGD (Arg-Gly-Asp) motif in its second external
loop. TheseRGDmotifs are generally present in ECMproteins (e.g.ﬁbro-
nectin, vitronectin) and bound by integrins in order to attach the cell
surface to the ECM. Wild-type AQP2 mediates the internalization of β1
integrin and thus prevents its accumulation at the cell surface. This pro-
cess supports cell migration by facilitating the turnover of integrins as
parts of focal adhesions. The expression of an AQP2 RGD/A mutant or
the absence of AQP2 leads to a considerable accumulation of β1 integrin
in the plasma membrane and a reduction in motility.
3.3. pH modulates cell adhesion and actin dynamics
Depending on the composition of their subunits integrins interact
with different proteins of the ECM. Various integrin dimers including
α2β1,α5,β1 andαvβ3 are sensitive to pH [96–98]. Hence, acidic extracel-
lular pH values induce conformational changes of the integrin mole-
cules leading to an enhanced avidity of the integrin headpieces to
ECM proteins [98], or they modulate the mechanical stability of focal
adhesions [99]. Since integrins protrudemerely 20 nm into the extracel-
lular space [100], rather the pericellular pH inside the glycocalyx than
the global extracellular pH of the surrounding bulk solution modulates
adhesion [96,101]. The pericellular pH is maintained by the proton-
expelling activity of NHE1. NHE1 appears to play a major role in many
tumors [102–104]. It is required for the motility of breast cancer, cervix
carcinoma and melanoma cells [105]. In migrating melanoma cells,
most of the NHE1 molecules accumulate at the leading edge where
they are constituents of focal adhesions [106]. Consequently, the
pericellular pH is more acidic at the cell front than at its rear end [101,
107], and the most acidic pericellular pH nanodomains are restricted
to focal adhesions at the cell front. These observations support the
idea that NHE1 activity locally stabilizes theβ1 integrin-mediated inter-
action between the cell surface and the ECM [106]. Not only in melano-
ma [108] but also in endothelial cells [109] the pericellular pH gradient
is mirrored by a complementary intracellular pH (pHi) gradient with
pHi being more alkaline at the cell front than at the cell rear. The
NHE1-dependent alkaline pHi at the cell front is thought to facilitate
focal adhesion turnover due to a lower afﬁnity of talin for binding
actin [110]. The alkaline pHi stimulates also coﬁlin-regulated cell motil-
ity [111]. The alkaline pHi abrogates the blockade of coﬁlin activity by
PI-(4,5)–P2-binding [112]. Coﬁlin then severs actin ﬁlaments and cre-
ates free barbed end actin. It thus establishes new sites of actin ﬁlament
assembly and fuels dynamic actin polymerization that accompaniesmembrane protrusion at the cell front or at the tip of invadopodia
[113]. The interaction between coﬁlin and cortactin depends on pHi as
well. The NHE1-mediated increase in pHi causes the release of
cortactin-bound coﬁlin which enables coﬁlin to generate free barbed
actin, eventually promoting the polymerization of actin [114]. The
more acidic pHi at the rear end activates the actin-binding protein
gelsolin that regulates actin assembly and disassembly [115], and a
neutral or slightly acidic pHi fosters the self-assembly of actin and the
binding of myosin to actin [116,117].
In summary, the activity of pH regulating transporters such as NHE1
[103] and NBCs [118] or AEs [119], frequently in cooperation with CAs
[20] and MCTs [120], creates the optimal pHi environment that drives
the actin dynamics required for the outgrowth of lamellipodia/
invadopodia.
NHE1 does not always play an exclusive, predominant role in the
pH-regulation of cancer cells. In humanbreast cancer carcinomas, for in-
stance, the expression of NBCn1 is twofold higher compared to normal
breast cancer tissue obtained from the same patient [118,121]. This is
accompanied by an increase in the clearly NBCn1-mediated cellular
net-acid extrusion (_HCO3− import) leading to an alkaline shift in the
steady-state pHi by ~0.3 pH units.
While NHE1 and NBCn1 compensate for cellular acidosis or cause an
increase in pHi by extruding protons or importing HCO3−, AE2 activity is
usually triggered by an intracellular alkalinization and then extrudes
HCO3− [122]. In human hepatocellular carcinoma AE2 is overexpressed
[123] and its inhibition induces apoptosis [124,125]. Induction of AE2
also contributes to colonic carcinogenesis through the activation of the
extracellular signal-regulated kinase (ERK) pathway which can be
blocked by AE2-targeted small interfering RNA (siRNA) or gastrin treat-
ment [126]. In gastric cancer cells, however, AE2, downregulation of
AE2 can be correlatedwith carcinogenesis which can be blocked by gas-
trin [127]. Gastrin stimulates the expression of AE2 in GC cells via early
growth response 1 (EGR1), in a cholecystokinin B receptor (CCKBR)
dependent manner [128].
3.4. Matrix metalloproteases (MMPs) and cathepsins clear the way
The outgrowth of invadopodia into the cell's surroundings requires
enough space usually generated by degrading or remodeling the ECM
[129]. Invadopodia secrete soluble enzymes with gelatinolytic activity
such as cathepsins B (andothers) [130] and thematrixmetalloproteases
MMP2 andMMP9 [131], or they displaymembrane-associated enzymes
such as MT1-MMP (MMP14) [132] in order to degrade the surrounding
ECM barrier. The action of several MMPs depends on the local, NHE1-
mediated acidiﬁcation at the cell surface of invadopodia [107,
133–135]: The protonation of the ECM-component ﬁbrinogen is essen-
tial for the MMP2 activity [136], and an acidic extracellular pH
upregulates the expression ofMMP9 [137]. Voltage-gatedNa+ channels
(Nav1.5) elevate the invasive potential of human breast cancer cells
[138] by increasing the activities of NHE1 [139] and cysteine cathepsins
[140]. The n-3 polyunsaturated docosahexaenoic acid (DHA), a natural
ligand of the peroxisome proliferator-activated receptor β (PPARβ),
inhibits Nav1.5 expression reducing both the Na+ current and NHE1
activity. Accordingly, DHA has no effect in cancer cells whose PPARβ ex-
pression is knocked down [4]. MMP activity can also be linked to Ca2+
signaling [141,142]. Since the upregulation of MMP9 demands Ca2+ in-
ﬂux, it can be antagonized by inhibiting voltage-gated Ca2+ channels
[143]. Interestingly, in the highly metastatic, human breast cancer cell
line MDA-MB-435s the activity of the ATP-gated Ca2+-permeable
P2X7 receptor increases invasion by the release of gelatinolytic cysteine
cathepsins [144].
4. Adhesion to the endothelium and extravasation
Once they arrive in the blood or lymph stream, only 0.01% out of the
circulating tumor cells will eventually form metastases [15], because of
2643C. Stock, A. Schwab / Biochimica et Biophysica Acta 1848 (2015) 2638–2646either immune surveillance or mechanical stress caused by the blood
ﬂow [145,146]. Several strategies help the cells to survive this mechan-
ical stress. They express high levels of stress proteins, e.g. the heat shock
protein HSP70, or they interact with ﬁbrinogen or platelets to form clots
protecting them against immune cells and facilitating their arrest and
their adhesion to the endothelium [147,148]. At this point, it remains
highly speculative as to what extent ion channels and transporters con-
tribute to the process of tumor cell adhesion to endothelial cells under
shear stress conditions. Numerous ion channels and transporters such
as KCa1.1, KCNK2, Nav1.5, NHE1 or members of the TRP and the Na+/
Ca2+ (NCX) exchanger families are mechanosensitive and can be acti-
vated by stretching the plasma membrane. It is imaginable that shear
stress could trigger their opening/activity or induce signaling mediated
by their mechanosensitive domains. Thus, shear stress could induce
pathways in tumor cells that induce the activation of integrins and
might eventually lead to adhesion of tumor cells to endothelial cells.
Kv11.1 (Erg1) channels physically and functionally interact with β1
integrins in many tumor cells including leukemias [149–151]. Kv11.1
and β1 integrins modulate each other's function by conformational
coupling. Integrin mediated adhesion activates Kv11.1 while integrin-
signaling such as the tyrosine phosphorylation of the focal adhesion
kinase (FAK) requires the activity of Kv11.1 [152]. Interestingly, FAK is
overexpressed in several invasive tumor cells which might enable
them to by-pass integrin signaling and thus survive in the absence of
adhesive contacts [153]. The question of whether a “hyperactive” FAK
known to form complexes with Kv2.1 [154] can – in reverse order –
promote integrin-mediated adhesion seems (too) adventurous and
needs to remain open. The Ca2+ activated Cl− channel CLCA2 could
play a major role in the adhesion of circulating tumor to endothelial
cells [155]. However, CLCA2 is expressed at the surface of endothelial
cells and, thus, can facilitate the arrest of β4 integrin expressing tumor
cells. Store-operated Ca2+ entry (SOCE) including the Ca2+ release-
activated calcium channel protein 1 (Orai1) are required for the extrav-
asation of nasopharyngeal carcinoma cells [156]. Finally, the step of
diapedesis could be facilitated by the Ca2+-dependent activation of
TMEM16A/ANO1. The resulting Cl− efﬂux would support local shrink-
age of the evading cell and thus help the cell to squeeze its way through
the endothelium into the target tissue [68].
5. Conclusion
Nearly each single step of themetastatic cascade includingmigration
and invasion depends on the presence or the activity of ion channels
and transporters. Different ion channels and transporters as well
as aquaporins cooperate in order to generate local pH or Ca2+
nanodomains required for adhesion, MMP activity and cytoskeletal dy-
namics. Others are constituents of focal adhesions, involved in signaling
processes or in targeting adhesionmolecules. Themultitude of channels
and transporters contributing to metastasis, and their multifaceted
ways of interaction represent an enormous number of targets for anti-
cancer therapeutics. It remains a big challenge to translate the present
knowledge on the role of ion transport in tumor cell motility, gained
from basic research and preclinical studies, into efﬁcient cancer
treatments. While a plethora of studies has demonstrated that a
prometastatic role of ion channels and transporters is beyond all ques-
tion, future studies should deal with questions of (i) how to deliver
efﬁcient drugs to poorly vascularized tissues, (ii) how to inhibit ion
transport in malignant cells without disturbing healthy cells that
express the same transport systems and (iii) how to take advantage of
a cocktail containing different drugs at low concentrations that would
not affect the transportome of healthy but exclusively ofmalignant cells.
Compared to the functions of ion channels and transporters in prolif-
eration, motility and invasion, very little is known about their contribu-
tion to the adhesion of circulating tumor cells to the endothelium or the
actual step of diapedesis under shear stress. It is worth looking into the
mechanisms by which ion transporters are involved in adhesion anddiapedesis, because during these events they display a better accessibil-
ity for a potential drug which then could be administered by intrave-
nous and intralymphatic injection. The efﬁciency of the lymphatic
circulation, however, may represent a limiting factor in distributing
the drug.
Targeting the process of EMT is also an option. But it requires the
exact knowledge of the differences between regular EMT needed for
wound healing, tissue repair and regeneration and that eventually
resulting in carcinogenesis.
Thus, future studies aiming at the characterization of the contribu-
tions of ion channels and transporters to both EMT and extravasation
of tumor cells are indicated.References
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